Jerry Braun

TL;DR: Among patients with (suspected) NSCLC, a staging strategy combining endosonography and surgical staging compared with surgical staging alone resulted in greater sensitivity for mediastinal nodal metastases and fewer unnecessary thoracotomies.

TL;DR: Residual mitral regurgitation was absent/minimal at 2-year follow-up, associated with a significant reduction in left atrial dimension and LV reverse remodeling and excellent results of combined restrictive annuloplasty and CABG were obtained.

TL;DR: Intermediate-term cutoff values for left ventricular reverse remodeling proved to be predictors for late mortality, and for patients with preoperative LVEDD of 65 mm or less, restrictive mitral annuloplasty with revascularization provides a cure for ischemic mitral regurgitation and heart failure; however, whenLVEDD exceeds 65 mm, outcome is poor and a ventricular approach should be considered.

TL;DR: Stringent restrictive mitral annuloplasty with or without revascularization provides excellent clinical results with acceptable mortality, and preoperative left ventricular end-diastolic dimension is identified as the single best factor in predicting occurrence of reverse remodeling.

TL;DR: Both preclinical and clinical studies evaluating the pathophysiology underlying vein graft failure, and the latest therapeutic options to improve patency for both coronary and peripheral grafts are described.